Status:
COMPLETED
The Volume Effect of Nerve Hydrodissection for Carpal Tunnel Syndrome
Lead Sponsor:
Tri-Service General Hospital
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Although many conservative managements of CTS, the...
Detailed Description
After obtaining written informed consent, patients clinically diagnosed with mild-to-moderate CTS were inclused and randomized into three groups. Group A, patients received one-session of ultrasoung-g...
Eligibility Criteria
Inclusion
- Age between 20-80 year-old.
- Diagnosis was confirmed using an electrophysiological study
Exclusion
- Cancer
- Coagulopathy
- Pregnancy
- Inflammation status
- Cervical radiculopathy
- Polyneuropathy, brachial plexopathy
- Thoracic outlet syndrome
- Previously undergone wrist surgery or steroid injection for CTS
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03381521
Start Date
August 1 2018
End Date
December 31 2022
Last Update
January 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital
Taipei, Neihu District, Taiwan, 886